Local-regional therapy of prostate cancer with 90Yttrium (90Y) radioembolization is a novel radiotherapy approach that delivers high-dose radiation therapy with minimal non-target radiation. However, currently no accurate way exists to evaluate radiation effects noninvasively following embolization. In this study, we sought to apply PET/MRI to assess biodistribution of 90Y and estimate effects of treatment following 90Y prostate artery radioembolization in a dog prostate model.
This abstract and the presentation materials are available to members only; a login is required.